# Multimodal Spatial Transcriptomics Reveals the Developing Human Liver Niche at Single-Cell Resolution

**Authors:** Michael Bailey, Michael Leon, Isabella Rosso, Carolyn Sangokoya

PMC · DOI: 10.1016/j.gastha.2026.100893 · 2026-02-03

## TL;DR

This study uses advanced imaging techniques to map the developing human liver's cellular environment at a high resolution, revealing how different cell types interact during development.

## Contribution

The novel integration of spatial transcriptomics and histology provides new insights into the liver's developmental niche and its role in hematopoiesis.

## Key findings

- Single-cell spatial imaging identified epithelial, hematopoietic, endothelial, and stromal cell populations in shared microenvironments.
- The study confirmed gene expression patterns in the developing ductal plate and CXC motif chemokine ligand localization in the hematopoietic stem cell niche.
- Integration of spatial transcriptomic markers can improve the characterization of developmental biliary biology and regenerative environments.

## Abstract

A comprehensive understanding of the liver niche during development provides insights into a unique, naturally occurring multifunctional multicellular environment. We applied spatial transcriptomic and histologic approaches to identify and histologically validate RNA-based markers in human liver tissue during a critical developmental window when the liver serves as the primary site of hematopoiesis, just prior to the rapid growth phase of the third trimester. During this period, the developmental liver niche uniquely supports the coexistence of endodermal- and mesenchymal-derived cell populations that coordinate hematopoietic development and hepatocyte function.

Nine formalin-fixed paraffin-embedded human developmental liver samples underwent histologic processing, staining, and evaluation prior to single-cell resolution spatial molecular imaging. Spatial transcriptomic profiling was followed by single-cell transcriptomic analysis and validation using multiplexed RNA fluorescent single-molecule in situ hybridization.

Single-cell spatial imaging identified epithelial, hematopoietic, endothelial, and stromal cell populations within shared microenvironments. This approach enabled molecular capture and histologic confirmation of 2 complex developmental phenomena: gene expression associated with the developing ductal plate and CXC motif chemokine ligand localization to the hepatic hematopoietic stem cell niche.

Integration of markers identified through spatial transcriptomics will expand molecular panel design and enable more precise characterization of developmental biliary biology and pathobiology. Importantly, RNA-based understanding of the functional diversity and in situ spatial organization of the developmental liver niche will also be essential for authenticating and re-engineering these complex regenerative environments in vitro.

## Linked entities

- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, PF4V1 (platelet factor 4 variant 1) [NCBI Gene 5197] {aka CXCL4L1, CXCL4V1, PF4-ALT, PF4A, SCYB4V1}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, AZU1 (azurocidin 1) [NCBI Gene 566] {aka AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC}, HBB (hemoglobin subunit beta) [NCBI Gene 3043] {aka CD113t-C, ECYT6, beta-globin}, IGHM (immunoglobulin heavy constant mu) [NCBI Gene 3507] {aka AGM1, MU, VH}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}, MT1X (metallothionein 1X) [NCBI Gene 4501] {aka MT-1l, MT1}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, S100A8 (S100 calcium binding protein A8) [NCBI Gene 6279] {aka 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, C1QC (complement C1q C chain) [NCBI Gene 714] {aka C1Q-C, C1QD3, C1QG}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, LYVE1 (lymphatic vessel endothelial hyaluronan receptor 1) [NCBI Gene 10894] {aka CRSBP-1, HAR, LYVE-1, XLKD1}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, APOC1 (apolipoprotein C1) [NCBI Gene 341] {aka APOC1B, Apo-CI, ApoC-I, apo-CIB, apoC-IB}, CD74 (CD74 molecule) [NCBI Gene 972] {aka CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, MARCO (macrophage receptor with collagenous structure) [NCBI Gene 8685] {aka SCARA2, SR-A6}, HMGB2 (high mobility group box 2) [NCBI Gene 3148] {aka HMG2}, MYL4 (myosin light chain 4) [NCBI Gene 4635] {aka ALC1, AMLC, GT1, PRO1957}, HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1) [NCBI Gene 3157] {aka CMYO28, HMGCS}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, IGFBP3 (insulin like growth factor binding protein 3) [NCBI Gene 3486] {aka BP-53, IBP-3, IBP3, IGFBP-3}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, GC (GC vitamin D binding protein) [NCBI Gene 2638] {aka DBP, DBP-maf, DBP/GC, GRD3, Gc-MAF, GcMAF}, TCL1A (TCL1 family AKT coactivator A) [NCBI Gene 8115] {aka TCL1}, MPO (myeloperoxidase) [NCBI Gene 4353], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, THBS1 (thrombospondin 1) [NCBI Gene 7057] {aka THBS, THBS-1, TSP, TSP-1, TSP1}, MEG3 (maternally expressed 3) [NCBI Gene 55384] {aka FP504, GTL2, LINC00023, Lnc-DLK1-35, NCRNA00023, PRO0518}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, DCN (decorin) [NCBI Gene 1634] {aka CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B}
- **Diseases:** duct (MESH:D001649), biliary atresia (MESH:D001656)
- **Chemicals:** glycogen (MESH:D006003), paraffin (MESH:D010232), eosin (MESH:D004801), formalin (MESH:D005557), 4',6-diamidino-2-phenylindole (MESH:C007293), Hematoxylin (MESH:D006416), urea (MESH:D014508)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966723/full.md

---
Source: https://tomesphere.com/paper/PMC12966723